Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Hilleman CEO On Tackling Regulatory Challenges For Vaccines

This article was originally published in Scrip

Executive Summary

Hilleman Laboratories' CEO, Dr Davinder Gill, is upbeat about the firm's tie-ups in Bangladesh for its "high-impact" cholera vaccine but underscores that it is critical to get the country's national regulatory authority (NRA) functional as quickly as possible to make such products available globally.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register